Clinical Trial Update: An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product [Phase 2]

View source ↗

Summary

Open-label extension study assessing safety of ForSight VISION5 product in Phase 2 for glaucoma conditions; completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• ForSight VISION5

Snippet

Sponsor: ForSight Vision5, Inc. | Conditions: Primary Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2019-02-26